CNBX Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
2
- Stock Symbol
-
CNBX
- Investments
-
3
CNBX Pharmaceuticals General Information
Description
CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the Cannabics SR, an oral capsule developed for the treatment of patients with cancer and cancer anorexia cachexia syndrome (CACS). It also has an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC) named RCC-33.
Contact Information
Website
www.cannabics.comCorporate Office
- 3 Bethesda Metro Center
- Suite 700
- Bethesda, MD 20814
- United States
Corporate Office
- 3 Bethesda Metro Center
- Suite 700
- Bethesda, MD 20814
- United States
CNBX Pharmaceuticals Stock Performance
As of 20-Nov-2026, CNBX Pharmaceuticals’s current market cap is $241K with 1.61B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $241K | 1.61B | 7.88M |
CNBX Pharmaceuticals Financials Summary
As of 31-May-2026, CNBX Pharmaceuticals has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-May-2026 | FY 2025 31-Aug-2025 | FY 2024 31-Aug-2024 | FY 2023 31-Aug-2023 |
|---|---|---|---|---|
| EV | 1,398 | 1,373 | 1,413 | 1,576 |
| Revenue | 0 | 0 | 130 | 410 |
| EBITDA | (432) | (274) | (603) | (3,547) |
| Net Income | (462) | (314) | (695) | (3,710) |
| Total Assets | 13 | 18 | 31 | 499 |
| Total Debt | 1,167 | 1,197 | 1,295 | 1,344 |
CNBX Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CNBX Pharmaceuticals Comparisons
Industry
Financing
Details
CNBX Pharmaceuticals Competitors (15)
One of CNBX Pharmaceuticals’s 15 competitors is PharmaCyte Biotech, a Corporation company based in Las Vegas, NV.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| PharmaCyte Biotech | Corporation | Las Vegas, NV | ||||
| Roche | Corporation | Basel, Switzerland | ||||
| Exact Sciences | Formerly VC-backed | Madison, WI | ||||
| Avenir Wellness Solutions | Formerly VC-backed | Oxnard, CA | ||||
| Skye Bioscience | Formerly VC-backed | San Diego, CA |
CNBX Pharmaceuticals Signals
CNBX Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CNBX Pharmaceuticals Investments & Acquisitions (3)
CNBX Pharmaceuticals’s most recent deal was a Merger/Acquisition with TaGeza Biopharmaceuticals. The deal was made on 08-Nov-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| TaGeza Biopharmaceuticals | 08-Nov-2022 | Merger/Acquisition | Drug Discovery | ||
| Wize Pharma/Cannabics Pharmaceuticals JV | 07-Feb-2019 | Joint Venture | Other Pharmaceuticals and Biotechnology | ||
| Sativus Tech | 17-Sep-2018 | Secondary Transaction - Private | Electrical Equipment |
CNBX Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
CNBX Pharmaceuticals Exits (1)
CNBX Pharmaceuticals’s most recent exit was on 17-Sep-2018 from Sativus Tech. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Sativus Tech | 17-Sep-2018 | Completed |
|
CNBX Pharmaceuticals FAQs
-
When was CNBX Pharmaceuticals founded?
CNBX Pharmaceuticals was founded in 2004.
-
Where is CNBX Pharmaceuticals headquartered?
CNBX Pharmaceuticals is headquartered in Bethesda, MD.
-
What is the size of CNBX Pharmaceuticals?
CNBX Pharmaceuticals has 2 total employees.
-
What industry is CNBX Pharmaceuticals in?
CNBX Pharmaceuticals’s primary industry is Biotechnology.
-
Is CNBX Pharmaceuticals a private or public company?
CNBX Pharmaceuticals is a Public company.
-
What is CNBX Pharmaceuticals’s stock symbol?
The ticker symbol for CNBX Pharmaceuticals is CNBX.
-
What is the current market cap of CNBX Pharmaceuticals?
The current market capitalization of CNBX Pharmaceuticals is $241K.
-
Who are CNBX Pharmaceuticals’s competitors?
PharmaCyte Biotech, Roche, Exact Sciences, Avenir Wellness Solutions, and Skye Bioscience are some of the 15 competitors of CNBX Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process